Letter to Shareholders Regarding Rafarma Acquisition by R. & D. Biocogency Laboratories Inc.
05 août 2020 09h15 HE
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) presents the following letter to Rafarma shareholders from CEO Vladimir Dolgolenko: To Our...